Avanos Medical AVNS Enteral feeding — Net Sales
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Avanos Medical in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Avanos Medical’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Avanos Medical's enteral feeding — net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Avanos Medical's enteral feeding — net sales?
- Avanos Medical (AVNS) reported enteral feeding — net sales of $84.6M in Q1 2026.
- How has Avanos Medical's enteral feeding — net sales changed year-over-year?
- Avanos Medical's enteral feeding — net sales increased by 13.6% year-over-year, from $74.5M to $84.6M.
- What is the long-term trend for Avanos Medical's enteral feeding — net sales?
- Over 2 years (2023 to 2025), Avanos Medical's enteral feeding — net sales has grown at a 5.4% compound annual growth rate (CAGR), from $283.3M to $314.7M.
- What does enteral feeding — net sales mean?
- This metric represents the total revenue generated from the sale of enteral feeding medical devices and related nutritional delivery products. It reflects the market demand and commercial performance of the company's specialized digestive health portfolio. Monitoring this figure helps investors assess the growth trajectory and competitive positioning of the company's clinical nutrition support business.